Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Barrett Esophagus × Lansoprazole × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Zollinger-Ellison Syndrome 1 Multiple Endocrine Neoplasia 1 Barrett Esophagus 1

Interventions

Esomeprazole 3 rofecoxib 1 Prednisolone 1 Omeprazole 1 Lansoprazole 1 Gastropexy 1 Fundoplication 1 Docosahexaenoic Acids 1 Dexlansoprazole 1 Cryotherapy 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00352261 2009-03-26

An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients

AstraZeneca

Phase 4 Completed

Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡